HH 349 (Hydrochlorothiazide and valsartan 25 mg / 320 mg)
Pill imprint HH 349 has been identified as Hydrochlorothiazide and valsartan 25 mg / 320 mg.
Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 320 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- HH 349
- Strength:
- 25 mg / 320 mg
- Color:
- Purple
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Solco Healthcare US, LLC
More about hydrochlorothiazide/valsartan
Consumer resources
- Valsartan/hydrochlorothiazide
- Hydrochlorothiazide and valsartan
- Valsartan and hydrochlorothiazide (Advanced Reading)
- Other brands: Diovan HCT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
